Dr. Novack selected for service award:

Dr. Novack was selected for the Merle Green Robertson Service Award by his alma mater, Robert Louis Stevenson High School. This award is given to an alum who demonstrates “service to society”.  Upon accepting the award, Dr. Novack said “I am honored by being selected by my fellow alumni to join the previous distinguished recipients of this award.  Honors by one’s peers are the most valuable.”  He recognized his teachers, his family who modeled volunteering, and his daughter, herself an alumna of the school.”

Dr. Novack's expertise in ophthalmic product development, from anterior to posterior, is demonstrated through his recent activities.

• Comprehensive review articles in top journals:
  • Novack GD. Pharmacotherapy for the Treatment of Choroidal Neovascularization Due to Age-Related Macular Degeneration. Ann Rev Pharmacol Toxicol 2008;48:61-78.
  • Novack GD. Ophthalmic drug delivery: Development and Regulatory Considerations. Clin Pharm Ther 2009;85:539-43.
• Participation at key pharmacology and ophthalmology meetings:
  • Invited speaker at AAO glaucoma sub-specialty day on new therapies.
  • Member, The Dry Eye Workshop (Pflugfelder SC, Geerling G, Kinoshita S, et al. Management and therapy of dry eye disease: Report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:163-78.
  • Invited speaker at NEI/FDA CDER Glaucoma Clinical Drug Trial Design and Endpoints Symposium (Rockville MD, Weinreb RN, Kaufman PL. Invest Ophthalmol Vis Sci 2009;50:1497-505.)
  • Speaker and organizer: Using Pharmaceuticals Off-Label: Be Concerned, Be Very Concerned: Symposium at ASCPT, Washington, DC.
  • Regulatory Issues in Ophthalmic Drug Development. 5th Annual Ophthalmic Drug Development and Delivery Summit, San Diego.
  • Moderator: Breaking news session at ASCPT, Washington, DC.
  • President, ASPET Drug Development Section.
• Among his volunteer activities, Dr. Novack has been a leader in supporting public higher education at the University of California:
  • President, UC Santa Cruz Alumni Association
  • Regent, University of California
  • President, UC Santa Cruz Foundation
  • Invited speaker at the Inauguration of the 10th chancellor of the University of California, Santa Cruz
• Recent assignments:
  • Develop scientific and regulatory material and represent start-up company for pre-IND meeting for retina indication.
  • Develop scientific and regulatory material and represent start-up company for pre-IND meeting for dry eye indication.
  • Represent start-up company for pre-NDA meeting for anterior segment indication.
  • Prepare IND for glaucoma indication.
  • Prepare publication plan for new glaucoma product.

As we reflect back on our 20 years, some of our key accomplishments are:

• As we reflect back on our 20 years, some of our key accomplishments are: Played a key role in the development of over 40 ophthalmic, dermatologic, and neurologic approved products
• NDA Firsts: First treatment for macular degeneration, First soft drug, First and second intravitreal drug delivery system
• Served over 350 clients in four continents on thousands of projects
• Contributed to over 100 IND and IDE submissions
• Organized and lead clients on scores of meetings with regulatory agencies worldwide
• Serving as a director of a publicly traded ophthalmic pharmaceutical firm, including raising over $100 million in financing
• Served as agent for a multi-million dollar licensing arrangement
• Created several business plans, including one funded at over $80 million
• Had our 160th paper printed in a peer-reviewed journal
• Published over 60 additional papers as medical writer, plus others as editor for non-English speakers
• Performed 100’s of literature and patent searches, including support for patent arbitration